Thursday 22 February | |
Anglo American PLC | Full Year Results |
Genus PLC | Half Year Results |
Hargreaves Lansdown PLC | Half Year Results |
Hays PLC | Half Year Results |
Hikma Pharmaceuticals PLC | Full Year Results |
Indivior PLC | Full Year Results |
Jupiter Fund Management PLC | Full Year Results |
Lloyds Banking Group PLC | Full Year Results |
ME Group International PLC | Full Year Results |
Mondi PLC | Full Year Results |
Morgan Sindall Group PLC | Full Year Results |
Pantheon International PLC | Half Year Results |
Rolls-Royce Holdings PLC | Full Year Results |
WPP PLC | Full Year Results |
Friday 23 February | |
City of London Investment Group PLC | Half Year Results |
Irish Residential Properties REIT PLC | Full Year Results |
Standard Chartered PLC | Full Year Results |
Monday 26 February | |
Base Resources Ltd | Half Year Results |
Bunzl PLC | Full Year Results |
EnSilica PLC | Half Year Results |
Kosmos Energy Ltd | Full Year Results |
Made Tech Group PLC | Half Year Results |
Tristel PLC | Half Year Results |
Tuesday 27 February | |
abrdn Equity Income Trust PLC | Full Year Results |
abrdn PLC | Full Year Results |
Croda International PLC | Full Year Results |
Kitwave Group PLC | Full Year Results |
McBride PLC | Half Year Results |
PCI-PAL PLC | Half Year Results |
Smith & Nephew PLC | Full Year Results |
Synectics PLC | Full Year Results |
Uniphar PLC | Full Year Results |
Unite Group PLC | Full Year Results |
Wednesday 28 February | |
AB Dynamics PLC | Trading Statement |
ASA International Group PLC | Trading Statement |
Aston Martin Lagonda Global Holdings PLC | Full Year Results |
Avingtrans PLC | Half Year Results |
Bluefield Solar Income Fund Ltd | Half Year Results |
Derwent London PLC | Full Year Results |
Glenveagh Properties PLC | Full Year Results |
Grit Real Estate Income Group Ltd | Half Year Results |
Hutchmed China Ltd | Full Year Results |
International Personal Finance PLC | Full Year Results |
Just Eat Takeaway.com NV | Full Year Results |
Primary Health Properties PLC | Full Year Results |
Reckitt Benckiser Group PLC | Full Year Results |
Renewables Infrastructure Group Ltd | Full Year Results |
RHI Magnesita NV | Full Year Results |
St James's Place PLC | Full Year Results |
Taylor Wimpey PLC | Full Year Results |
Comments and questions to newsroom@alliancenews.com | |
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
Copyright 2024 Alliance News Ltd. All Rights Reserved. |
IN BRIEF: China grants Hutchmed's savolitinib breakthrough therapy tag
Hutchmed (China) Ltd - Hong Kong-based developer of treatments for cancer and immunological diseases - Wins 'breakthrough therapy designation' in China for its gastric cancer treatment, savolitinib. The BTD is granted by the National Medical Products Administration. It is for the treatment of locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with mesenchymal epithelial transition factor amplification who have failed at least two lines of standard therapies. Hutchmed notes that MET-driven gastric cancer has a poor prognosis, and China grants a BTD to new drugs that treat life-threatening diseases for which there are no effective treatment options.
Read more